An Innovative Approach to Extending the Antidepressant Effects of Intravenous Ketamine in Major Depression. Schatzberg AF. Am J Psychiatry 2022;179:890-891.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Schatzberg AF. An Innovative Approach to Extending the Antidepressant Effects of Intravenous Ketamine in Major Depression. Am J Psychiatry 2022;179:890-891.
PMID: 36453033